Ken Griffin Ab Cellera Biologics Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$2.73 - $4.73 $3,822 - $6,622	-1,400 Reduced 4.31%	31,100 $92,000
Q1 2024 May 15, 2024	SELL	$4.29 - $5.97 $1.2 Million - $1.66 Million	-278,700 Reduced 89.56%	32,500 $147,000
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $151,317 - $229,491	-38,700 Reduced 11.06%	311,200 $1.78 Million
Q3 2023 Nov 14, 2023	BUY	$4.6 - $7.95 $256,679 - $443,610	55,800 Added 18.97%	349,900 $1.61 Million
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $94,522 - $126,753	-16,700 Reduced 5.37%	294,100 $1.9 Million
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $368,424 - $563,472	-50,400 Reduced 13.95%	310,800 $2.34 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $368,772 - $564,828	-38,900 Reduced 9.72%	361,200 $3.66 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $323,840 - $481,536	35,200 Added 9.65%	400,100 $3.96 Million

165

119M

239K

200K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $681M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.